Germany is faster than other countries & has a better treatment strategy – This is shown the latest data.
In the past it has already been shown that Germany is very successful in treating cancer of all forms. Germany is one of the most expensive health systems that patients benefit from. Patients have access to the latest and most expensive therapies.
A new study shows, that access to new cancer drugs is unbeatable in Germany.
In addition, no other country in Europe has so many newly developed cancer drugs available. Of the 31 oncological medicines approved in 2015 to 2017, 30 are on market in Germany.
Example the numbers from other countries:
Finland (21), Spain (19),
What makes Germany unique in this regard. Doctors are allowed to make more decisions and work independently. They work for the patient and are not the puppets of the system. We got these words from a Swedish cancer patient who has now been successfully treated in Germany and is in remission with his cancer.
I find out, Germany has the best cancer management worldwide
for the temporary relief of arthritis pain.
Voltaren Arthritis Pain is a nonsteroidal anti-inflammatory drug (NSAID) and works by reducing substances in the body that cause pain and inflammation. This product, previously referred to as Voltaren Gel 1%, was first approved by the FDA in 2007 as a prescription drug and was indicated for the relief of the pain of osteoarthritis of joints responsive to topical treatment, in particular, the joints of the hands, knees and feet. It has not been shown to work for strains, sprains, bruises or sports injuries.
Voltaren Arthritis Pain is intended for the temporary relief of joint pain due to the most common type of arthritis, osteoarthritis, which increases with age, affects millions of people in the U.S., and can generally be self-diagnosed. Arthritis is the swelling and tenderness of one or more of your joints. Symptoms of arthritis include pain, swelling, stiffness, and difficulty moving a joint.
The process of changing the status of a drug from prescription to nonprescription is called an Rx-to-OTC switch. It is usually initiated by the manufacturer of the prescription drug. For a drug to switch to nonprescription status, the data provided must demonstrate that the drug is safe and effective for use in self-medication as directed in proposed labeling. The manufacturer must show that consumers can understand how to use the drug safely and effectively without the supervision of a healthcare professional.
ist eine seltene Form des Schlafapnoe, was ca 20% vorkommt. Die häufigste Form ist die zentraler Schlafapnoe (Cheyne-Stokes-Atmung = CSA), Patienten mit dieser Form, haben eine eine schwerer Herzinsuffizienz.
Patienten die an ZSA erkrankt sind, schnarchen nicht oft, sodass die Krankheit nicht immer erkannt wird.
Wie behandelt man eine zentrale Schlafapnoe mit einer begleitende Herzerkrankung?
- Eine optimale Einstellung in der medikamentöser Therapie bei Herzinsuffizienz
- CRT – Cardiale Resynchronisationstherapie
- Atemunterstützungen durch CPAP oder BIPAP, so wie die richtigen Atemmaske